FRANÇAIS                   
Marie-France Beauchesne

 

 

Clinical Associate Professor

M. Sc. (Pharm.), Pharm. D.

 


Pavillon Jean-Coutu, Room 2175
Telephone: 514-343-2154
Fax: 514-343-6120
Email : marie-france.beauchesne@umontreal.ca

 

Chaire pharmaceutique AstraZeneca en santé respiratoire

 

Teaching Domains

  • Pharmacotherapy of asthma, COPD and endocrinologic disorders
  • Evidence-based pharmacotherapy

     

Research Themes

  • Asthma education

  • Asthma and pregnancy

  • Respiratory medication utilisation review

  • Pharmaceutical care in respiratory disease

Current Research Projects

  • Evaluation of a caremap, towards patients with respiratory disease, in the community pharmacy setting

  • Intervention by community pharmacists to improve adherence to maintenance medication for the treatment of asthma

     

Selected Publications

Balter M, Ernst P, Watson W, Kim H, Ciccuto L, Beauchesne MF, Cave A, Kapplan A, Hogg D, McIvor A, Smiley T, Rouleau M, Fitzgerald JM. Asthma Worsenings : approaches to prevention and management from the asthma worsenings working group. Can Respir J 2008;15(Suppl B):1B-19B.

René-Henri N, Khamla Y, Nadaira N, Ouellet C, Blais L, Lalonde L, Collin J, Beauchesne MF. Community Pharmacist’s Interventions in Asthma Care: A Descriptive Study. Ann Pharmacotherapy 2008, Epub ahead of print.

Cyr MC, Beauchesne MF, Lemiere C, Blais L. Effects of theophyllines on the rate of moderate to severe exacerbations among patients with COPD. B J Clin Pharmacol 2008;65(1):40-50.

Beauchesne MF, Nenciu LM, Dinh TA, Tassé M, Fillion A, Labrecque M,  Blais L. Active communication of a pharmacy discharge plan for patients with respiratory diseases: a pilot study. J Pharm Technol 2007;23:67-74.

Rouleau R, Laurier C, Beauchesne M.-F. The Impact of a continuing education program on community pharmacists’ interventions and asthma medication usage: a pilot study. Ann Pharmacother 2007;41:574-80.

Martel MJ, Rey E, Beauchesne MF, Perreault S, Forget A, Maghni K, Lefebvre G, Blais L. Use of short-acting beta-2 agonists during pregnancy and the risk of pregnancy-induced hypertension.  J Allergy Clin Immunol 2007;119(3):576-82.

Firoozi F, Lemière C, Beauchesne MF, Forget A, Blais L. Development and validation of database indexes of asthma severity and control. Thorax 2007;62(7):581-587.

Blais L, Beauchesne MF, Rey E, Malo JL, Forget A. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women. Thorax 2007;62:320-8.

 

Last uptade :  2010-04-14

© 2009 - Faculté de pharmacie